SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-23-000044
Filing Date
2023-11-02
Accepted
2023-11-02 14:53:00
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20230930.htm   iXBRL 10-Q 1677330
2 EX-31.1 bmrn-exx311xq32023.htm EX-31.1 9252
3 EX-31.2 bmrn-exx312xq32023.htm EX-31.2 9242
4 EX-32.1 bmrn-exx321xq32023.htm EX-32.1 5143
  Complete submission text file 0001048477-23-000044.txt   7739994

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20230930.xsd EX-101.SCH 45999
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20230930_cal.xml EX-101.CAL 74043
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20230930_def.xml EX-101.DEF 231402
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20230930_lab.xml EX-101.LAB 627678
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20230930_pre.xml EX-101.PRE 403552
64 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20230930_htm.xml XML 1319847
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 231371619
SIC: 2834 Pharmaceutical Preparations